Phase II Study of Nivolumab and Ramucirumab for Patients with Previously-Treated Mesothelioma: Hoosier Cancer Research Network LUN15-299

Status: Open to Accrual

Learn more:

• clinicaltrials.gov: NCT03502746
• See news release

Study Contact: studies@hoosiercancer.org; (317) 921-2050.